Sending warm wishes and cheer

December 21, 2016

Dear Shareholders,

A sincere note to wish all of you a special and very happy holiday season.

Our expectations as we move into the New Year are for the expanded ‘discovery’ of AsepticSure® and the wonders it offers for safer hospitals, not to mention the many other applications for the science. With regulatory approvals for US market entry now in hand and a solid FDA and EPA registered manufacturing partner in place with Cogmedix, we feel prepared. They are a company that we place great faith in as partners for this journey as we move into the future holding the anticipation of demand based manufacturing growth and product delivery requirements.

On December 15th, we held a meeting of shareholders in Salt Lake City. We thank our lead outside counsel, Durham, Jones and Pinegar, for graciously offering excellent accommodations and their support for the meeting. Management considers the meeting a success and thanks to all of our shareholders for your votes on the various proxy measures. An SEC Form 8K filing of the final voting results can be viewed by following the enclosed link.

While these meetings are always lightly attended, we wish to thank all of our shareholders that voted their proxy as well as those that attended. Currently, Medizone International has 2,305 shareholders of record with our stock transfer agent, American Stock Transfer and Trust and an additional 5,083 shareholders holding street stock in brokerage accounts.

Given the current level of interest we are seeing in AsepticSure, both in the United States and from other regions, we truly believe that we are now entering a year of expanded product recognition and acceptance. This is expected to lead to profitability, sustainable revenues and encouraging growth curves as we progress through the latter half of 2017.

We should always remember that while there are other products competing in the same market space, not one of them is capable of demonstrating what AsepticSure achieves. This truly is a revolutionary science that is destined to become the Gold Standard for the disinfection of enclosed spaces.

Being cautious and also realistic, please do not expect things to happen over night. Programs, production and opportunities are coming together. We are very optimistic and feel prepared for the coming growth we envision. I hope shareholders understand that this is the beginning of a new and exciting stage for our company so they can enjoy the journey. We only see upside from here.

May each of you enjoy a wonderful holiday. As an FYI, both our Canadian and US facilities will be closed from Christmas Eve, which is also the beginning of Hanukkah this year. We will reopen following New Year’s.

Blessings to all,
Edwin G. Marshall
Chairman of the Board
Chief Executive Officer

This Web Site Posting may contain certain forward looking statements that could involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company’s filings made with the Securities and Exchange Commission.

 

For press information on Medizone International, please contact:

John Pentony, Investor and Media Relations
Medizone International, Inc.
T: 01 415 331-0202
E: j.pentony@medizoneint.com

For more information, visit:
http://www.medizoneint.com
Email: operations@medizoneint.com

AsepticSure Hospital Disinfection System Expands North American Patent Coverage

San Francisco, California, December 12, 2016 – Medizone International, Inc. (The Company) (OTCQB:MZEI)  Following its recently announced EPA approval to enter the US market with its WHO Award winning and peer reviewed AsepticSure® Hospital Disinfection Technology,  the Company today announces Mexico has agreed to grant  a patent for its HEALTHCARE FACILITY DISINFECTING PROCESS AND SYSTEM WITH OXYGEN/OZONE MIXTURE.  This patent essentially conformed with the claims to those previously granted for the European Union. Countries that have now granted coverage for this revolutionary hospital disinfection technology include Canada, the United States, Mexico, China, Singapore, The United Kingdom, France and Germany with additional applications pending and processing.

Additional patent grants for BIO-TERRORISM COUNTERACTION USING OZONE AND HYDROGEN PEROXIDE have been granted by the United States, The United Kingdom, France and Germany.

A patent covering SPORTS EQUIPMENT AND FACILITY DISINFECTION has been granted in the United States and a Notice of Allowance received for Canada.

Medizone’s Chairman of the Board and CEO Edwin Marshall commented, “developing and proving a room disinfection system that consistently achieves 100% kill of all vegetative and spore forming bacteria as well as viral pathogens throughout the entire space being disinfected utilizing a ‘green’ technology has proven to be a considerable journey.  Management is excited about our US market entry and is pleased that International patent authorities continue to recognize the unique nature of this science and continue to grant the company patent protection for what is sure to be greatly expanding commercial opportunity as we move into 2017.”

This Press Release may contain certain forward looking statements that could involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company’s filings made with the Securities and Exchange Commission.

 

For press information on Medizone International, please contact:

John Pentony, Investor and Media Relations
Medizone International, Inc.
T: 01 415 331-0202
E: j.pentony@medizoneint.com

For more information, visit:

http://www.medizoneint.com
Email: operations@medizoneint.com

 

Medizone International, Inc. (OTCQB: MZEI)

4000 Bridgeway, Suite 401
Sausalito, CA 94965

Telephone: 415-331-0303

Email: operations@medizoneint.com

Media and Investor Relations:

John Pentony

Medizone International, Inc.

Telephone: (415) 331-0202

Email: j.pentony@medizoneint.com

Social Media


Twitter:


https://twitter.com/asepticsure

CONTACT:

Medizone International, Inc. (OTCQB: MZEI)
4000 Bridgeway, Suite 401
Sausalito, CA 94965

Telephone: 415-331-0303

Email: operations@medizoneint.com

INVESTOR & MEDIA RELATIONS:

John Pentony
Medizone International, Inc.

Telephone: (415) 331-0202E:

Email: j.pentony@medizoneint.com

SOCIAL MEDIA:

Medizone International on Twitter:

https://twitter.com/asepticsure